Drug Type Biological products |
Synonyms- |
Target |
Action modulators |
Mechanism SLIT2 modulators(slit guidance ligand 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | United States | 29 Apr 2025 | |
Squamous Cell Carcinoma of Head and Neck | Preclinical | United States | 29 Apr 2025 |